Our Remarkable Milestones

Clinical Studies

Ranking first in conducting clinical studies with world-class standards, pioneering in the field.

Publishing Over 20 Articles

Publishing over 20 articles in the world's most reputable journals.

Easy Access to Medications

Ensuring nationwide accessibility to OrchidPharmed's covered medications.

Online Education

Enabling consumers to connect with esteemed Iranian physicians across the nation, whether they're in close proximity or farther from the capital, through online educational avenues.

Support 24/7 Consumers

Providing continuous, seven-day support around the clock, guiding consumers and enhancing their contentment.

Exercitationem ab aut

Exercitationem ab aut
Exercitationem ab aut
Exercitationem ab aut
Exercitationem ab aut
Exercitationem ab aut
Exercitationem ab aut

Latest Articles

Drawing on their knowledge and expertise, the OrchidPharmed's Research and Development team has achieved the publication of over twenty reputable scientific articles in esteemed journals worldwide. You can explore some of these articles right here.

Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study
Publication year: 2021
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial
Publication year: 2021
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management
Publication year: 2021
Orchid Life's MS Page

This page is designed with the objective of raising awareness, disseminating information, and providing consultation regarding Multiple Sclerosis (MS). OrchidLife is dedicated to supporting MS patients and preventing its onset by consistently producing up-to-date and scientific content in this field